129 related articles for article (PubMed ID: 34572270)
21. Fusion to an albumin-binding domain with a high affinity for albumin extends the circulatory half-life and enhances the in vivo antitumor effects of human TRAIL.
Li R; Yang H; Jia D; Nie Q; Cai H; Fan Q; Wan L; Li L; Lu X
J Control Release; 2016 Apr; 228():96-106. PubMed ID: 26951928
[TBL] [Abstract][Full Text] [Related]
22. The effect of gene copy number and co-expression of chaperone on production of albumin fusion proteins in Pichia pastoris.
Shen Q; Wu M; Wang HB; Naranmandura H; Chen SQ
Appl Microbiol Biotechnol; 2012 Nov; 96(3):763-72. PubMed ID: 22885695
[TBL] [Abstract][Full Text] [Related]
23. RSM optimization of HSA/IL1Ra in Pichia pastoris overexpression strain and study of its in vivo activity in reducing hyperglycemia of GK rats.
Liu W; Zhao W; Lai J; Shen Q; Xu Y; Pan L; Chen S
Biotechnol Appl Biochem; 2017 Sep; 64(5):627-637. PubMed ID: 27572239
[TBL] [Abstract][Full Text] [Related]
24. Circumventing the heterogeneity and instability of human serum albumin-interferon-alpha2b fusion protein by altering its orientation.
Zhao HL; Xue C; Wang Y; Li XY; Xiong XH; Yao XQ; Liu ZM
J Biotechnol; 2007 Sep; 131(3):245-52. PubMed ID: 17698234
[TBL] [Abstract][Full Text] [Related]
25. In vivo pharmacokinetics, immunogenicity and mechanism of PEGylated antitumor polypeptide.
Liu Z; Li W; Xu HM; Huang X; Pan L; Ren Y; Yang Y; Li Y; Pu C; Zhang C
Curr Pharm Des; 2012; 18(12):1655-62. PubMed ID: 22283767
[TBL] [Abstract][Full Text] [Related]
26. Construction and characterization of a potent, long-lasting recombinant human serum albumin-interferon α1 fusion protein expressed in Pichia pastoris.
Tian S; Li Q; Yao W; Xu C
Protein Expr Purif; 2013 Aug; 90(2):124-8. PubMed ID: 23748141
[TBL] [Abstract][Full Text] [Related]
27. Expression, purification, and characterization of recombinant human serum albumin fusion protein with two human glucagon-like peptide-1 mutants in Pichia pastoris.
Dou WF; Lei JY; Zhang LF; Xu ZH; Chen Y; Jin J
Protein Expr Purif; 2008 Sep; 61(1):45-9. PubMed ID: 18556214
[TBL] [Abstract][Full Text] [Related]
28. Production of N
Chen J; Li H; Wang T; Sun S; Liu J; Chen J
Oncotarget; 2017 Nov; 8(56):95247-95255. PubMed ID: 29221124
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics and biodistribution of human serum albumin-TIMP-2 fusion protein using near-infrared optical imaging.
Lee MS; Kim YH; Kim YJ; Kwon SH; Bang JK; Lee SM; Song YS; Hahm DH; Shim I; Han D; Her S
J Pharm Pharm Sci; 2011; 14(3):368-77. PubMed ID: 21962154
[TBL] [Abstract][Full Text] [Related]
30. Expression, purification, and lipolytic activity of recombinant human serum albumin fusion proteins with one domain of human growth hormone in Pichia pastoris.
Wang F; Wu M; Liu W; Shen Q; Sun H; Chen S
Biotechnol Appl Biochem; 2013; 60(4):405-11. PubMed ID: 23750891
[TBL] [Abstract][Full Text] [Related]
31. Increasing the homogeneity, stability and activity of human serum albumin and interferon-alpha2b fusion protein by linker engineering.
Zhao HL; Yao XQ; Xue C; Wang Y; Xiong XH; Liu ZM
Protein Expr Purif; 2008 Sep; 61(1):73-7. PubMed ID: 18541441
[TBL] [Abstract][Full Text] [Related]
32. [Expression in Pichia pastoris and properties of human serum albumin-interferon alpha2b chimera].
Chang SH; Gong X; Yang ZY; Wang TY; Ma GC; Ma QJ; Wu J
Sheng Wu Gong Cheng Xue Bao; 2006 Mar; 22(2):173-9. PubMed ID: 16607939
[TBL] [Abstract][Full Text] [Related]
33. TAT-HSA-α-MSH fusion protein with extended half-life inhibits tumor necrosis factor-α in brain inflammation of mice.
Wang M; Zhi D; Wang H; Ru Y; Ren H; Wang N; Liu Y; Li Y; Li H
Appl Microbiol Biotechnol; 2016 Jun; 100(12):5353-61. PubMed ID: 26816094
[TBL] [Abstract][Full Text] [Related]
34. Linker length affects expression and bioactivity of the onconase fusion protein in Pichia pastoris.
Yang GG; Xu XY; Ding Y; Cui QQ; Wang Z; Zhang QY; Shi SH; Lv ZY; Wang XY; Zhang JH; Zhang RG; Xu CS
Genet Mol Res; 2015 Dec; 14(4):19360-70. PubMed ID: 26782589
[TBL] [Abstract][Full Text] [Related]
35. Development of a long acting FGF21 analogue-albumin fusion protein and its anti-diabetic effects.
Watanabe H; Miyahisa M; Chikamatsu M; Nishida K; Minayoshi Y; Takano M; Ichimizu S; Kobashigawa Y; Morioka H; Maeda H; Maruyama T
J Control Release; 2020 Aug; 324():522-531. PubMed ID: 32450094
[TBL] [Abstract][Full Text] [Related]
36. AlbuCatcher for Long-Acting Therapeutics.
Rho JH; Lee JH; Kwon I
ACS Omega; 2024 May; 9(21):22990-23000. PubMed ID: 38826564
[TBL] [Abstract][Full Text] [Related]
37. Constitutive expression of a rhIL-2-HSA fusion protein in Pichia pastoris using glucose as carbon source.
Guan B; Chen F; Lei J; Li Y; Duan Z; Zhu R; Chen Y; Li H; Jin J
Appl Biochem Biotechnol; 2013 Dec; 171(7):1792-804. PubMed ID: 23999737
[TBL] [Abstract][Full Text] [Related]
38. [Construction of IL-1Ra-HSA fusion protein and analysis of its bioactivity and pharmacokinetics].
Huang Y; Hu L; Yang YQ; Hu XP; Zhen YS; Liu MY
Yao Xue Xue Bao; 2012 Sep; 47(9):1210-8. PubMed ID: 23227553
[TBL] [Abstract][Full Text] [Related]
39. In-vivo delivery of therapeutic proteins by genetically-modified cells: comparison of organoids and human serum albumin alginate-coated beads.
Shinya E; Dervillez X; Edwards-Lévy F; Duret V; Brisson E; Ylisastigui L; Lévy MC; Cohen JH; Klatzmann D
Biomed Pharmacother; 1999 Dec; 53(10):471-83. PubMed ID: 10665341
[TBL] [Abstract][Full Text] [Related]
40. Effects of co-overexpression of secretion helper factors on the secretion of a HSA fusion protein (IL2-HSA) in pichia pastoris.
Guan B; Chen F; Su S; Duan Z; Chen Y; Li H; Jin J
Yeast; 2016 Nov; 33(11):587-600. PubMed ID: 27532278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
